Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner

Inflammatory bowel disease (IBD) is a global health problem in which gut microbiota dysbiosis plays an important pathogenic role. However, the current drugs for IBD treatment are far from optimal. Previous researches indicated that parthenolide (PTL) had not only anti-cancer properties but also stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yao-Jiang, Tang, Bo, Wang, Feng-Chao, Tang, Li, Lei, Yuan-Yuan, Luo, Ya, Huang, Sheng-Jie, Yang, Min, Wu, Ling-Yi, Wang, Wei, Liu, Shuang, Yang, Shi-Ming, Zhao, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196297/
https://www.ncbi.nlm.nih.gov/pubmed/32373209
http://dx.doi.org/10.7150/thno.43716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196297/
https://www.ncbi.nlm.nih.gov/pubmed/32373209
http://dx.doi.org/10.7150/thno.43716

Ejemplares similares